TrialBMJ open2022
What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015-2020).
Kristina Jenei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it